Weeks 2448 (post-peak): Even without dose reduction, heart rate partially declines from its peak
Although large studies such as the SELECT trial provide important safety data, a median follow-up of approximately 40 months is insufficient to capture late-onset oncogenesis
Typical applications include: Obesity and Weight-Management Models : Evaluating how dual amylin + GLP-1 signaling influences body weight, waist measures, and energy intake in animal models and clinical research settings
Compounded semaglutide contains the same active molecule as Wegovy
Quality of Life Enhancement: Weight loss, stable blood glucose, and pain relief improve physical function scores (e.g., WOMAC scale)
doi: 10.3389/fendo.2021.749451 141 ZhaoXYHeQYZengYMChengL